SK Biopharmaceuticals and Eurofarma formed a joint venture to develop an AI platform for managing epilepsy. The focus includes real-time seizure prediction and a community for patient communication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback